A Swedish court has ruled that a product containing CBD for oral consumption cannot automatically be classified as a pharmaceutical, but that the legal status of each product must be assessed individually ...
Restricted content. Do you want to read more?
Sign up NOW for 7 days FREE TRIAL and access our briefings section
CBD-Intel provides impartial, independent and premium market and regulatory analysis, legal tracking, and quantitative data for the cannabidiol (CBD) sector worldwide. Most content is available to subscribers only.